COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score
- PMID: 23218087
- PMCID: PMC3541923
- DOI: 10.1016/j.mayocp.2012.10.013
COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score
Abstract
Objective: To develop a concise and statistically robust instrument to assess autonomic symptoms that provides clinically relevant scores of autonomic symptom severity based on the well-established 169-item Autonomic Symptom Profile (ASP) and its validated 84-question scoring instrument, the Composite Autonomic Symptom Score (COMPASS).
Patients and methods: We assessed the internal consistency of COMPASS using Cronbach α coefficients based on the ASP of 405 healthy control subjects recruited and seen in the Mayo Clinic Autonomic Disorders Center between March 1, 1995, and March 31, 2010. Applying a simplified scoring algorithm, we then used exploratory factor analysis with orthogonal rotation and eigenvalue calculations to extract internally consistent domains and to reduce dimensionality. This analysis was followed by expert revisions to eliminate redundant content and to retain clinically important questions and final assessment of the new instrument.
Results: The new simplified scoring algorithm alone resulted in higher Cronbach α values in all domains. Factor analysis revealed 7 domains with a total of 54 questions retained. Expert revisions resulted in further reduction of questions and domains with a remaining total of 31 questions in 6 domains (COMPASS 31). Measures of internal consistency were much improved compared to those for COMPASS. Following appropriate weighting, this instrument provides an autonomic symptom score from 0 to 100.
Conclusion: COMPASS 31 is a refined, internally consistent, and markedly abbreviated quantitative measure of autonomic symptoms. It is based on the original ASP and COMPASS, applies a much simplified scoring algorithm, and is suitable for widespread use in autonomic research and practice.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Validation of the Composite Autonomic Symptom Score 31 in the German language.Neurol Sci. 2022 Jan;43(1):365-371. doi: 10.1007/s10072-021-05764-4. Epub 2021 Nov 25. Neurol Sci. 2022. PMID: 34820747 Free PMC article.
-
The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms.Neurology. 1999 Feb;52(3):523-8. doi: 10.1212/wnl.52.3.523. Neurology. 1999. PMID: 10025781
-
Symptoms of Autonomic Dysfunction in Systemic Sclerosis Assessed by the COMPASS-31 Questionnaire.J Rheumatol. 2018 Aug;45(8):1145-1152. doi: 10.3899/jrheum.170868. Epub 2018 Jun 15. J Rheumatol. 2018. PMID: 29907667 Free PMC article.
-
Validation and reliability of the Turkish version of the composite autonomic symptom score 31.Neurol Sci. 2024 Dec;45(12):5779-5786. doi: 10.1007/s10072-024-07776-2. Epub 2024 Sep 24. Neurol Sci. 2024. PMID: 39313686
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.Nat Commun. 2022 Aug 30;13(1):5104. doi: 10.1038/s41467-022-32507-6. Nat Commun. 2022. PMID: 36042189 Free PMC article.
-
Current Concepts in the Treatment of Multiple System Atrophy.Mov Disord Clin Pract. 2015 Feb 2;2(1):6-16. doi: 10.1002/mdc3.12145. eCollection 2015 Mar. Mov Disord Clin Pract. 2015. PMID: 30363880 Free PMC article. Review.
-
Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy.Clin Auton Res. 2019 Sep;29(Suppl 1):25-31. doi: 10.1007/s10286-019-00624-w. Epub 2019 Sep 10. Clin Auton Res. 2019. PMID: 31506870 Free PMC article. Review.
-
Low-Dose Naltrexone Use in Postural Orthostatic Tachycardia Syndrome: A Case Series.Cureus. 2023 Aug 13;15(8):e43426. doi: 10.7759/cureus.43426. eCollection 2023 Aug. Cureus. 2023. PMID: 37706146 Free PMC article.
-
Assessment of comorbid symptoms in pediatric autonomic dysfunction.Clin Auton Res. 2023 Dec;33(6):843-858. doi: 10.1007/s10286-023-00984-4. Epub 2023 Sep 21. Clin Auton Res. 2023. PMID: 37733160 Review.
References
-
- Suarez G.A., Opfer-Gehrking T.L., Offord K.P., Atkinson E.J., O'Brien P.C., Low P.A. The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology. 1999;52(3):523–528. - PubMed
-
- Benrud-Larson L.M., Dewar M.S., Sandroni P., Rummans T.A., Haythornthwaite J.A., Low P.A. Quality of life in patients with postural tachycardia syndrome. Mayo Clin Proc. 2002;77(6):531–537. - PubMed
-
- Benrud-Larson L.M., Sandroni P., Haythornthwaite J.A., Rummans T.A., Low P.A. Correlates of functional disability in patients with postural tachycardia syndrome: preliminary cross-sectional findings. Health Psychol. 2003;22(6):643–648. - PubMed
-
- Benrud-Larson L.M., Sandroni P., Schrag A., Low P.A. Depressive symptoms and life satisfaction in patients with multiple system atrophy. Mov Disord. 2005;20(8):951–957. - PubMed
-
- Low P.A., Benrud-Larson L.M., Sletten D.M., European MSA-Study Group Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care. 2004;27(12):2942–2947. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical